Study Details To evaluate the safety and dose range of DAA-I after single oral dose administration
Protocol Number DAA-I
Phase I
Therapeutic Area Endocrinology
Subject Types Healthy
Indication No indication
Principal Investigator Professor Lee Kok Onn
Investigator Product / Device DAA-I
Sponsor NUHS
Previous Clinical Trials
Next Clinical Trials
Top